182 related articles for article (PubMed ID: 20573726)
1. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health.
Koncarevic A; Cornwall-Brady M; Pullen A; Davies M; Sako D; Liu J; Kumar R; Tomkinson K; Baker T; Umiker B; Monnell T; Grinberg AV; Liharska K; Underwood KW; Ucran JA; Howard E; Barberio J; Spaits M; Pearsall S; Seehra J; Lachey J
Endocrinology; 2010 Sep; 151(9):4289-300. PubMed ID: 20573726
[TBL] [Abstract][Full Text] [Related]
2. Increased muscle force production and bone mineral density in ActRIIB-Fc-treated mature rodents.
Chiu CS; Peekhaus N; Weber H; Adamski S; Murray EM; Zhang HZ; Zhao JZ; Ernst R; Lineberger J; Huang L; Hampton R; Arnold BA; Vitelli S; Hamuro L; Wang WR; Wei N; Dillon GM; Miao J; Alves SE; Glantschnig H; Wang F; Wilkinson HA
J Gerontol A Biol Sci Med Sci; 2013 Oct; 68(10):1181-92. PubMed ID: 23525481
[TBL] [Abstract][Full Text] [Related]
3. Treatment with soluble activin type IIB-receptor improves bone mass and strength in a mouse model of Duchenne muscular dystrophy.
Puolakkainen T; Ma H; Kainulainen H; Pasternack A; Rantalainen T; Ritvos O; Heikinheimo K; Hulmi JJ; Kiviranta R
BMC Musculoskelet Disord; 2017 Jan; 18(1):20. PubMed ID: 28103859
[TBL] [Abstract][Full Text] [Related]
4. ActRIIB:ALK4-Fc alleviates muscle dysfunction and comorbidities in murine models of neuromuscular disorders.
Li J; Fredericks M; Cannell M; Wang K; Sako D; Maguire MC; Grenha R; Liharska K; Krishnan L; Bloom T; Belcheva EP; Martinez PA; Castonguay R; Keates S; Alexander MJ; Choi H; Grinberg AV; Pearsall RS; Oh P; Kumar R; Suragani RN
J Clin Invest; 2021 Feb; 131(4):. PubMed ID: 33586684
[TBL] [Abstract][Full Text] [Related]
5. Co-Administration of Myostatin-Targeting siRNA and ActRIIB-Fc Fusion Protein Increases Masseter Muscle Mass and Fiber Size.
Bayarsaikhan O; Kawai N; Mori H; Kinouchi N; Nikawa T; Tanaka E
J Nutr Sci Vitaminol (Tokyo); 2017; 63(4):244-248. PubMed ID: 28978871
[TBL] [Abstract][Full Text] [Related]
6. Prevention of cachexia-like syndrome development and reduction of tumor progression in inhibin-deficient mice following administration of a chimeric activin receptor type II-murine Fc protein.
Li Q; Kumar R; Underwood K; O'Connor AE; Loveland KL; Seehra JS; Matzuk MM
Mol Hum Reprod; 2007 Sep; 13(9):675-83. PubMed ID: 17704537
[TBL] [Abstract][Full Text] [Related]
7. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis.
Morrison BM; Lachey JL; Warsing LC; Ting BL; Pullen AE; Underwood KW; Kumar R; Sako D; Grinberg A; Wong V; Colantuoni E; Seehra JS; Wagner KR
Exp Neurol; 2009 Jun; 217(2):258-68. PubMed ID: 19285073
[TBL] [Abstract][Full Text] [Related]
8. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
Allen DL; Cleary AS; Speaker KJ; Lindsay SF; Uyenishi J; Reed JM; Madden MC; Mehan RS
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E918-27. PubMed ID: 18334608
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial impairment induced by postnatal ActRIIB blockade does not alter function and energy status in exercising mouse glycolytic muscle in vivo.
Béchir N; Pecchi É; Relizani K; Vilmen C; Le Fur Y; Bernard M; Amthor H; Bendahan D; Giannesini B
Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E539-49. PubMed ID: 26837807
[TBL] [Abstract][Full Text] [Related]
10. A Soluble Activin Receptor IIB Fails to Prevent Muscle Atrophy in a Mouse Model of Spinal Cord Injury.
Graham ZA; Collier L; Peng Y; Saéz JC; Bauman WA; Qin W; Cardozo CP
J Neurotrauma; 2016 Jun; 33(12):1128-35. PubMed ID: 26529111
[TBL] [Abstract][Full Text] [Related]
11. Evidence from the aged orchidectomized male rat model that 17beta-estradiol is a more effective bone-sparing and anabolic agent than 5alpha-dihydrotestosterone.
Vandenput L; Boonen S; Van Herck E; Swinnen JV; Bouillon R; Vanderschueren D
J Bone Miner Res; 2002 Nov; 17(11):2080-6. PubMed ID: 12412816
[TBL] [Abstract][Full Text] [Related]
12. Treatment with Soluble Activin Type IIB Receptor Ameliorates Ovariectomy-Induced Bone Loss and Fat Gain in Mice.
Puolakkainen T; Rummukainen P; Pihala-Nieminen V; Ritvos O; Savontaus E; Kiviranta R
Calcif Tissue Int; 2022 Apr; 110(4):504-517. PubMed ID: 35024891
[TBL] [Abstract][Full Text] [Related]
13. Soluble activin type IIB receptor improves fracture healing in a closed tibial fracture mouse model.
Puolakkainen T; Rummukainen P; Lehto J; Ritvos O; Hiltunen A; Säämänen AM; Kiviranta R
PLoS One; 2017; 12(7):e0180593. PubMed ID: 28704409
[TBL] [Abstract][Full Text] [Related]
14. Activin type IIB receptor blockade does not limit adenosine triphosphate supply in mouse skeletal muscle in Vivo.
Béchir N; Pecchi É; Vilmen C; Bernard M; Bendahan D; Giannesini B
Muscle Nerve; 2018 Dec; 58(6):834-842. PubMed ID: 30025155
[TBL] [Abstract][Full Text] [Related]
15. Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy.
Morvan F; Rondeau JM; Zou C; Minetti G; Scheufler C; Scharenberg M; Jacobi C; Brebbia P; Ritter V; Toussaint G; Koelbing C; Leber X; Schilb A; Witte F; Lehmann S; Koch E; Geisse S; Glass DJ; Lach-Trifilieff E
Proc Natl Acad Sci U S A; 2017 Nov; 114(47):12448-12453. PubMed ID: 29109273
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice.
Lawlor MW; Read BP; Edelstein R; Yang N; Pierson CR; Stein MJ; Wermer-Colan A; Buj-Bello A; Lachey JL; Seehra JS; Beggs AH
Am J Pathol; 2011 Feb; 178(2):784-93. PubMed ID: 21281811
[TBL] [Abstract][Full Text] [Related]
17. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
[TBL] [Abstract][Full Text] [Related]
18. Lasofoxifene (CP-336,156), a selective estrogen receptor modulator, prevents bone loss induced by aging and orchidectomy in the adult rat.
Ke HZ; Qi H; Crawford DT; Chidsey-Frink KL; Simmons HA; Thompson DD
Endocrinology; 2000 Apr; 141(4):1338-44. PubMed ID: 10746637
[TBL] [Abstract][Full Text] [Related]
19. Administration of a soluble activin type IIB receptor promotes the transplantation of human myoblasts in dystrophic mice.
Fakhfakh R; Lee SJ; Tremblay JP
Cell Transplant; 2012; 21(7):1419-30. PubMed ID: 22449443
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction.
Pistilli EE; Bogdanovich S; Mosqueira M; Lachey J; Seehra J; Khurana TS
Am J Physiol Regul Integr Comp Physiol; 2010 Jan; 298(1):R96-R103. PubMed ID: 19864340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
